CHINA: Third vaccines 66% effective; no new local infections reported .

Third Chinese Covid-19 Vaccine Was 66% Effective in Late-Stage Study The early clinical trial results potentially give China a third effective vaccine candidate in fighting the pandemic. Chao Deng WSJ

TAIPEI, Taiwan—Early clinical trial results from several countries showed that a Covid-19 vaccine candidate jointly developed by the Chinese military and a private Chinese firm was 65.7% effective at preventing symptomatic cases of the coronavirus, potentially giving China a third effective vaccine candidate in fighting the pandemic.

The results from late-stage trials—which were first made public in a tweet by Faisal Sultan, special assistant on national health to Pakistan’s prime minister—come as global public-health experts have called for more transparency from Beijing and Chinese drugmakers on the efficacy and safety of their Covid-19 vaccines.

The candidate, developed by CanSino Biologics Inc. in conjunction with the Chinese military, is being tested in five countries: Pakistan, Russia, Argentina, Mexico and Chile. ...

ALSO SEE: China reports no new local COVID-19 infection for first time in nearly two months